← Back to Browse
ProductImaging and Diagnostics

Amyloid Brain PET Quantification System

South Korea

An AI-powered clinical device for accurate automated quantification of amyloid brain PET imaging using deep neural networks without MRI. This system enables fast and precise diagnostic assessment for neurodegenerative diseases.

Manufactured by

Brightonix Imaging Inc.

South Korea

Brightonix Imaging Inc. (BRTNX) is a startup founded in October 2016. With the mission to "overcome diseases and improve human health by visualizing the interior of the living body non-invasively using various photons," it is the only company in Korea engaged in the development, manufacturing, and sales of PET (Positron Emission Tomography) systems—molecular imaging medical devices that detect radiation. PET is a research and clinical imaging device used to diagnose cancers and brain diseases (such as dementia) by detecting radiation to reconstruct functional phenomena, such as metabolism within the body, into 3D images.

View profile & products →

✦ Product-Specific Coverage

AI supplier coverage for this product

Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.

Generated for this product

AI-matched supplier coverage based on related product alternatives.

0
Relevant manufacturers
matched to this product
0
Relevant products analyzed
for supplier coverage
0
Sourcing countries
identified

AI-Matched Alternative Products

from other manufacturers

AI-Matched Alternative Products

from other manufacturers

3 of 39 closest product alternatives

39 products

36 more product alternatives available

Create a free account to compare more product alternatives and supplier options.

Get Free Access →

© 2026 Suplivia · Home · Browse Products